Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/07/2003WO2002046386A3 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003WO2002033119A3 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
08/07/2003WO2002008381A3 Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
08/07/2003US20030150010 Comprises nucleotide sequences coding thioredoxin h protein for improving baking quality of cereal flour; neutralization of venomons; food processing
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149996 Method for producing polyclonal and monoclonal antibodies
08/07/2003US20030149531 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/07/2003US20030149256 Transferrin polynucleotides, polypeptides, and antibodies
08/07/2003US20030149247 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
08/07/2003US20030149246 Macromolecular conjugates and processes for preparing the same
08/07/2003US20030149244 Adjusting affinity of Fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents
08/07/2003US20030149242 Novel polypeptide
08/07/2003US20030149241 Nucleotide sequences coding osteogenic protein for induction/differentiation and/or treatment of bone, cartilage and other connective tissue defects; wound healing agents
08/07/2003US20030149237 G-protein coupled receptor for treatment and prevention of eating, cancer, autoimmune, vision and nervous sytem disorders; antiinflammatory agents
08/07/2003US20030148982 Bi-spcific chimeric T cells
08/07/2003US20030148972 Hereditary hemochromatosis gene
08/07/2003US20030148958 For therapy and prophylaxis of muscular dystrophy
08/07/2003US20030148957 Corticotropin releasing factor 2 receptor agonists
08/07/2003US20030148956 For therapy and prophylaxis of muscular dystrophy
08/07/2003US20030148951 Human EMR2, a G-protein coupled receptor from the EGF_TM7 family
08/07/2003US20030148947 MIP as a research tool for identification, characterization and purification of molecules involved in cellular transport and osmotic regulation; agonists/antagonists; vision defects; anitinflammatory agents; nervous system and kidney disorders
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148932 Antitumor agents comprising an oligopeptide conjugated with a chemotherapy agent that attacks the cell-surface protein expressed by erbB-2 ocogene; prophylaxis of people at genetic risk; detection of tumors
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148508 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
08/07/2003US20030148491 Comprises receptor-like protein tyrosine phosphatase polypeptides (DEP-1) for use as antiinflammatory/anticarcinogenic agents
08/07/2003US20030148484 Comprises genetically engineered growth factor precursor for use as genetic vaccine; immunoassays
08/07/2003US20030148468 Method of preparing antibody by gene immunization
08/07/2003US20030148463 Novel method for the production of anti-human antigen receptors and uses thereof
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148446 Acute neuronal induced calcium binding protein type 1 ligand
08/07/2003US20030148444 Sodium-independent small neutral amino acid transporters transporting L- and D-amino acids and genes thereof
08/07/2003US20030148443 Epoxide hydrolases, nucleic acids encoding them and methods of making and using them
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148426 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148425 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148423 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148420 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase
08/07/2003US20030148419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148409 Genetically engineered monoclonal di/tri/tetra antibodies preferential tumor associated antigens for use in diagnosis and treatment of tumors
08/07/2003US20030148408 Compositions and methods for the diagnosis and treatment of tumor
08/07/2003US20030148406 Multivalent antigen-binding proteins
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148392 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening
08/07/2003US20030148389 Schizophrenia related gene and protein
08/07/2003US20030148388 Patched genes and uses related thereto
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148381 More protein-protein interactions in the inner ear
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148374 Immunloglobulin for use in diagnosis of brain/nervous system disorders associated with viral infections
08/07/2003US20030148373 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148372 Comprises nucleotide sequence repertoire coding antibody polypeptides; anticarcinogenic/antiinflammatory/antiarthritic agents; antiallergens; bactericides; viricides
08/07/2003US20030148371 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148370 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148369 Novel uses of mammalian CCR8 receptors and related reagents
08/07/2003US20030148364 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
08/07/2003US20030148333 HCV anti-core monoclonal antibodies
08/07/2003US20030148312 Measuring the expression level of MAL gene; atopic dermatitis and bronchial asthma
08/07/2003US20030148306 Aggrecanase molecules
08/07/2003US20030148294 DNA encoding novel chemokine receptors
08/07/2003US20030148272 Sandwich assays for collagen type i fragments
08/07/2003US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein
08/07/2003US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents
08/07/2003US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof
08/07/2003US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003US20030147910 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
08/07/2003US20030147906 Monoclonal antibodies, which are capable of binding the immunoglobulin E regions, use in medicine as passive immunotherapy or immunoprophylaxis
08/07/2003US20030147905 Administering an oligopeptide for immunotherapy
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens
08/07/2003US20030147900 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes there of
08/07/2003US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells
08/07/2003US20030147893 Novel human transmembrane 4 superfamily protein
08/07/2003US20030147891 Administering to a human patient at least one anti-TNF(tumor necrosis factor) monoclonal antibody, or a TNF binding fragment for treating neurodegenerative diseases
08/07/2003US20030147890 Administering a monoclonal antibody which is a murine anti-human IL-8 monoclonal antibody, for treating skin inflammatory diseases
08/07/2003US20030147889 Administering type 1-interferon antibody, for inhibition of prevention of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis and psoriasis
08/07/2003US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
08/07/2003US20030147886 Novel antibody compositions for preparing enriched dendritic cell preparations
08/07/2003US20030147885 Administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies for treating B cell lymphoma
08/07/2003US20030147884 Administering a breast cancer patient (caused by human ErbB2 oncogene which codes a transmebrane glycoprotein receptor related to epidermal growth factor receptor, is overexpressed) an anti ErbB2 antibody and a drug
08/07/2003US20030147882 Administering to the patient an effective dose of an immunoglobulin polypeptide or fragment which binds to an amyloid fibril, thus enhance cellular immune response of a patient to remove diseased amyloid fibril deposit
08/07/2003US20030147881 Directed against a target antigen, cell culture to express, code the protein, for treating cancer
08/07/2003US20030147872 B lymphocytes treated with an antigen; treating or preventing diseases, a liposome encapsulation
1 ... 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 ... 1494